Comparison of the Clinical Frailty Scale and the FRAIL Scale for Predicting Short-Term Outcomes in Older Adults Hospitalized with Infectious Diseases: A Multicentre Prospective Study
In a multicentre prospective study of older adults hospitalized with infectious diseases in Türkiye, the Clinical Frailty Scale demonstrated superior prognostic performance compared to the FRAIL Scale for predicting adverse short-term outcomes, including mortality and discharge delays.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
As people live longer, hospitals are seeing more older adults admitted for infections like pneumonia or urinary tract infections. While age is a known factor in how sick a person might get, doctors have long suspected that a person's biological condition matters even more than their birth date. This condition is called frailty. It is not simply about being weak or moving slowly; it is a state where the body's systems have lost their reserve, making it harder to bounce back from stress like an illness. When an older person gets sick, a frail body has less capacity to fight the infection and recover, often leading to longer stays in the hospital or worse outcomes. To help doctors spot this vulnerability early, researchers use different tools to measure frailty. Two of the most common tools are the Clinical Frailty Scale, which asks a doctor to look at a patient's overall health, memory, and daily abilities, and the FRAIL Scale, which is a short checklist of five questions about fatigue, walking, and weight loss. The big question for medical teams is which of these tools actually does a better job of predicting who will struggle most during a hospital stay.
A team of researchers across sixteen hospitals in Turkey set out to answer this question by watching what happened to older patients admitted for infectious diseases. They followed 151 patients who were sixty-five years or older. On the day each patient was admitted, the medical team at each hospital used both the Clinical Frailty Scale and the FRAIL Scale to rate how frail the patient was. The researchers then tracked these patients for twenty-eight days to see if they were discharged, transferred to an intensive care unit, or passed away. They wanted to see which scale was better at predicting these short-term outcomes. The study found that both tools identified many patients as frail, but they did not agree on who was at the highest risk. The FRAIL Scale, which relies on a simple questionnaire, identified about two-thirds of the patients as frail. However, when the researchers looked at the results, this scale did not strongly predict who would die or who would need intensive care. It could tell that a patient was frail, but it could not reliably tell which of those frail patients would have the worst outcome.
In contrast, the Clinical Frailty Scale proved to be a much sharper tool for prediction. This scale, which requires a doctor to make a judgment based on the patient's overall fitness, comorbidities, and mental state, identified slightly fewer patients as frail, but those it flagged were the ones who actually struggled. The patients rated as frail by this scale were significantly more likely to die within twenty-eight days compared to those rated as non-frail. They were also less likely to be discharged and more likely to have a poor overall outcome, such as needing intensive care or remaining in the hospital. When the researchers compared the two tools directly, the Clinical Frailty Scale was clearly superior at distinguishing between patients who would recover and those who would not. It was able to separate the high-risk patients from the low-risk ones with much greater accuracy than the questionnaire-based FRAIL Scale.
The study also revealed that the number of medications a patient was taking was a common thread among those identified as frail by both tools. Patients taking five or more different medicines were more likely to be labeled frail, and this group of patients tended to stay in the hospital longer. However, the number of medications alone did not predict death or the need for intensive care as well as the Clinical Frailty Scale did. The researchers found that age itself was not the deciding factor for a bad outcome; a seventy-year-old who was robust could do better than a seventy-year-old who was frail, and the frailty scales helped make that distinction. The study suggests that while the FRAIL Scale is a quick way to screen for physical weakness, the Clinical Frailty Scale offers a more complete picture of a patient's vulnerability. By looking at the whole person—their mind, their mobility, and their other health problems—doctors can better identify which older adults are at the greatest risk when they come in with an infection. This finding supports the idea that routine checks for frailty should become a standard part of care for older patients, helping medical teams prepare for the challenges ahead and tailor their treatment to the individual's true biological condition.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.